AI Portfolio Summary
In 2025 Q4, Foresite Capital Management IV, LLC maintained a portfolio of 7 distinct positions. The most significant new addition to the portfolio was Alector, Inc., which now represents 2.64% of the total fund value.
Total Positions
7
Quarter
2025 Q4
Top Holding
PHVS (57.7%)
Top 10 Concentration
100.0%
Turnover Rate
23.4%
Sector HHI
0.18
Items per page:
Showing 1-7 of 7
| Stock | History | Sector / Type | Port % | Prev % | Rank / Prev | Conviction | Change | % Change | Influence | Shares | Mkt Value | Avg Cost | Price Held | 1st Owned | Source | Source Date | Date Reported |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
PHVS
Pharvaris N.V.
|
Healthcare | 57.73% | 65.29% |
#1
Prev: #1
|
7.0 | no change | no change |
P
S
|
4,778,581 | $132,605,623 | 2021 Q1 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
CYTK
CYTOKINETICS IN...
|
Healthcare | 12.68% | 13.79% |
#2
Prev: #2
|
6.5 | no change | no change |
P
S
|
458,295 | $29,120,064 | 2018 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
LYEL
Lyell Immunopha...
|
Healthcare | 10.72% | 7.12% |
#3
1
Prev: #4
|
6.0 | no change | no change |
P
S
|
800,399 | $24,636,281 | 2021 Q2 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
MAZE
Maze Therapeuti...
|
Healthcare | 9.43% | 7.42% |
#4
1
Prev: #3
|
5.3 | no change | no change |
P
S
|
522,657 | $21,653,680 | 2025 Q1 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
RLAY
Relay Therapeut...
|
Healthcare | 3.68% | 2.86% |
#5
1
Prev: #6
|
3.0 | no change | no change |
P
S
|
1,000,000 | $8,460,000 | 2020 Q3 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
XENE
Xenon Pharmaceu...
|
Healthcare | 3.12% | 3.52% |
#6
1
Prev: #5
|
2.2 | no change | no change |
P
S
|
160,000 | $7,171,200 | 2018 Q3 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
ALEC
Alector, Inc.
|
Healthcare | 2.64% | — |
#7
Prev: #—
|
4.6 | 3,887,200 | no change |
NEW
|
3,887,200 | $6,064,032 | 2019 Q1 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) |
Showing 1-7 of 7 holdings